Answers are grounded in this paper and cite their sources.
Randomized trial evaluates liver function improvement from dietary intervention in Tbc1d4-deficient mice, suggesting metabolic benefits.
Background and aims: The Rab-GTPase activating protein (RabGAP) TBC1D4 (AS160) plays a crucial role in glucose homeostasis by facilitating glucose uptake from the blood into skeletal muscle and adipose tissue. In Arctic populations, a muscle-specific nonsense mutation (p.Arg684Ter) in the Tbc1d4 gene has been associated with postprandial hyperglycemia, hyperinsulinemia and a substantially elevated Type 2 Diabetes Mellitus (T2D) risk. This variant is hypothesized to represent an evolutionary adaptation to the traditional lifestyle of indigenous populations, which is characterized by a diet high in protein and low in carbohydrate content (Arctic diet). A previous study has shown that Greenlanders with T2D have a more favourable outcome on liver complications caused by diabetes, compared to a reference population. The aim of our study is to gain a better understanding of the role of the liver in Tbc1d4-deficency and the interactions between insulin-responsive tissues. To this end, we assess liver function in Tbc1d4-deficient mice after a dietary intervention with either an Arctic or a Western diet high in saturated fats and carbohydrates.
No takes yet. Share an insight, caveat, or question.
Förster et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: